𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The optimal use of bexarotene in cutaneous T-cell lymphoma

✍ Scribed by R. Gniadecki; C. Assaf; M. Bagot; R. Dummer; M. Duvic; R. Knobler; A. Ranki; P. Schwandt; S. Whittaker

Book ID
108669515
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
220 KB
Volume
157
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CD8+ cutaneous T-cell lymphoma successfu
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: A case report and review of the literature
✍ Srivalli Gopaluni; Raiza Perzova; Lynn Abbott; Ramsey Farah; Anthony Shrimpton; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## Abstract CD8+ cutaneous T‐cell lymphoma (CTCL) is a relatively rare subset of the non‐Hodgkins lymphomas. Bexarotene has been FDA‐approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report